Clinical trial
Cognitive Effects of Androgen Receptor Directed Therapies for Advanced Prostate Cancer
NCT03016741
Study timeline
Study start (actual)2017-03-31Date precision: day
Registry last updated2026-02-24
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Castration-Resistant Prostatic Cancerunresolved
Metastatic Prostate Carcinomaunresolved
Recurrent Prostate Carcinomaunresolved
Stage IV Prostate Cancerunresolved
Hormone-Refractory Prostate Cancerunresolved
Interventions
GnRH agonist/antagonistBIOLOGICAL
PrednisoneDRUG · verified · RxNorm: prednisone
Abiraterone AcetateDRUG · verified · RxNorm: abiraterone acetate
EnzalutamideDRUG · verified · RxNorm: enzalutamide
Sponsors & collaborators
Northwestern Universitylead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT03016741 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.